Article Information
History
- August 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kristin L. Andrejko, PhD1,2,*,
- Jennifer F. Myers, MPH1,*,
- Nozomi Fukui1,
- Lauren Nelson, MPH1,
- Rui Zhao, MPH1,
- John Openshaw, MD1,
- James P. Watt1, MD, MPH,
- Seema Jain, MD1,
- Joseph A. Lewnard, PhD2,3,4,†,#,
- Jake M. Pry, PhD, MPH1,5,†,# and
- the California COVID-19 Case-Control Study Team§
- 1California Department of Public Health, Richmond, California, United States
- 2Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California, United States
- 3Division of Infectious Diseases & Vaccinology, School of Public Health, University of California, Berkeley, California, United States
- 4Center for Computational Biology, College of Engineering, University of California, Berkeley, California, United States
- 5Department of Public Health Sciences, School of Medicine, University of California, Davis, California, United States
- ↵#Corresponding authors: Jake M. Pry, PhD, MPH, 850 Marina Bay Parkway, Richmond, California 94804, United States, Tel.: +1 936-661-6885, E-mail: jake.pry{at}cdph.ca.gov | jmpry{at}ucdavis.edu, Joseph A. Lewnard, PhD, 2121 Berkeley Way, Berkeley, California 94720, United States, Tel.: +1 (510) 664-4050, E-mail: jlewnard{at}berkeley.edu
↵* KLA and JFM contributed equally to the study.